Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 2 of the 13 calendar months from Oct 2025 to Oct 2026: Nov 2025 and Jan 2026.
- Largest single sale: $4.6M (34,588 shares) of Neurocrine Biosciences Inc on Jan 16, 2026. Filing
- Last sale before this period: Feb 13, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Neurocrine Biosciences Inc (NBIX) | Chief Executive Officer, Director | Jan 28, 2013 | Sep 15, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Sep 11, 2026, Neurocrine Biosciences Inc: 8,117 shares awarded; 4,380 shares withheld by the company for taxes. 1 filing: 1
- Feb 13, 2026, Neurocrine Biosciences Inc: 4,807 shares vested; 7,973 shares withheld by the company for taxes; 9,968 shares awarded. 1 filing: 1
- Feb 12, 2026, Neurocrine Biosciences Inc: 4,907 shares vested; 2,648 shares withheld by the company for taxes. 1 filing: 1
- Jan 31, 2026, Neurocrine Biosciences Inc: 2,927 shares vested; 1,580 shares withheld by the company for taxes. 1 filing: 1
- Jan 16, 2026, Neurocrine Biosciences Inc: sold 36,400 shares for $4.8M, under a disclosed plan; 36,400 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.